Medacta Group SA
SIX:MOVE
Medacta Group SA
Cash from Operating Activities
Medacta Group SA
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medacta Group SA
SIX:MOVE
|
Cash from Operating Activities
€75.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Cash from Operating Activities
CHf9.2m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Cash from Operating Activities
CHf715.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Straumann Holding AG
SIX:STMN
|
Cash from Operating Activities
CHf483.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Medmix Ltd
SIX:MEDX
|
Cash from Operating Activities
CHf86.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Medacta Group SA
Glance View
Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.
See Also
What is Medacta Group SA's Cash from Operating Activities?
Cash from Operating Activities
75.1m
EUR
Based on the financial report for Dec 31, 2023, Medacta Group SA's Cash from Operating Activities amounts to 75.1m EUR.
What is Medacta Group SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
2%
Over the last year, the Cash from Operating Activities growth was 2%. The average annual Cash from Operating Activities growth rates for Medacta Group SA have been 8% over the past three years , 2% over the past five years .
You don't have any saved screeners yet